GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Treasury Stock

MYND Life Sciences (XCNQ:MYND) Treasury Stock : C$0.00 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. MYND Life Sciences's treasury stock for the quarter that ended in Jan. 2024 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


MYND Life Sciences Treasury Stock Historical Data

The historical data trend for MYND Life Sciences's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Treasury Stock Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
Treasury Stock
- - -

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MYND Life Sciences Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


MYND Life Sciences (XCNQ:MYND) Business Description

Traded in Other Exchanges
Address
05-2248 Elgin Ave., Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.

MYND Life Sciences (XCNQ:MYND) Headlines

From GuruFocus

Mynd.ai, Inc. Consummates Merger Transaction

By PRNewswire 12-13-2023